Literature DB >> 20146101

An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.

Hao-Xian Yang1, Ying Xu, Jian-Hua Fu, Jun-Ye Wang, Peng Lin, Tie-Hua Rong.   

Abstract

BACKGROUND: The current American Joint Committee on Cancer (AJCC) staging system for esophageal cancer does not define the minimum number of lymph nodes (LNs) necessary for accurate nodal staging. This study aimed to seek the minimum number of LNs examined for adequate nodal staging of patients with node-negative esophageal cancer.
METHODS: We conducted a retrospective review of 592 patients undergoing R0 resection with node-negative esophageal carcinoma between December 1996 and December 2004. The relationship between the total number of examined LNs and death from esophageal cancer was investigated by means of a scatterplot of this variable versus Martingale residuals from a Cox proportional hazard regression model without the variable of interest. A smoothed line fit of the scatterplot was applied to detect the reasonable cutoff point.
RESULTS: The patients were classified into four categories according to the number of examined LNs: < or =5, 6 to 9, 10 to 17, and > or =18. A reduced hazard ratio of death was observed with an increasing number of LNs examined. The 5-year cancer-specific survival rate was 42.8% among patients with < or =5 LNs examined, compared with 52.6, 56.8, and 75% for those with 6-9 LNs, 10-17 LNs, and > or =18 LNs, respectively. Multivariate Cox regression analysis suggested that female sex, lower grade of cell differentiation, lower T category and increasing number of examined LNs were independent factors favoring cancer-specific survival.
CONCLUSIONS: At least 18 LNs should be resected for accurate staging of operable esophageal carcinoma. However, a validation from other institute is warranted.

Entities:  

Mesh:

Year:  2010        PMID: 20146101     DOI: 10.1245/s10434-010-0948-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  34 in total

1.  Recurrence risk model for esophageal cancer after radical surgery.

Authors:  Jincheng Lu; Hua Tao; Dan Song; Cheng Chen
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

2.  Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.

Authors:  Chen Wei; Wen-Ying Deng; Ning Li; Wei Shen; Chi Zhang; Jia-Yu Liu; Su-Xia Luo
Journal:  Dig Dis Sci       Date:  2015-05-05       Impact factor: 3.199

3.  Negative lymph node at station 108 is a strong predictor of overall survival in esophageal cancer.

Authors:  Jinling Zhang; Xueyuan Heng; Yi Luo; Luning Li; Haiyan Zhang; Fengyuan Che; Baosheng Li
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

Review 4.  The significance of lymph node status as a prognostic factor for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

Review 5.  Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition).

Authors:  Hui Li; Wentao Fang; Zhentao Yu; Yousheng Mao; Longqi Chen; Jie He; Tiehua Rong; Chun Chen; Haiquan Chen; Keneng Chen; Ming Du; Yongtao Han; Jian Hu; Jianhua Fu; Xiaobin Hou; Taiqian Gong; Yin Li; Junfeng Liu; Shuoyan Liu; Lijie Tan; Hui Tian; Qun Wang; Jiaqing Xiang; Meiqing Xu; Xin Ye; Bin You; Renquan Zhang; Yan Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

6.  Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery.

Authors:  Bo Ye; Chen-Xi Zhong; Yu Yang; Wen-Tao Fang; Teng Mao; Chun-Yu Ji; Zhi-Gang Li
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

7.  Preoperative chemoradiation therapy decreases the number of lymph nodes resected during esophagectomy.

Authors:  Adamu Issaka; Nezih Onur Ermerak; Zeynep Bilgi; Volkan Hasan Kara; Cigdem Ataizi Celikel; Hasan Fevzi Batirel
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

8.  Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.

Authors:  Guoping Xu; Ming Jin; Yingjie Shao; Yuan Chen; Zhonghua Ning
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

9.  Lymph Node Harvest During Esophagectomy Is Not Influenced by Use of Neoadjuvant Therapy or Clinical Disease Stage.

Authors:  Renato A Luna; James P Dolan; Brian S Diggs; Nathan W Bronson; Brett C Sheppard; Paul H Schipper; Brandon H Tieu; Benjamin T Feeney; Ken M Gatter; Gina M Vaccaro; Charles R Thomas; John G Hunter
Journal:  J Gastrointest Surg       Date:  2015-04-25       Impact factor: 3.452

Review 10.  Lymph node dissection for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.